{"name":"RAGE Bio","slug":"rage-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQY3hMYk9qTlBXRmNHdlJOME8xVTg3OWZPd0R0YW9uUzVYY2hsb1Z1b0RZV2FwTE16M1VUMlNlNEJESnVrbEdKVXdnd05hTndIRmx2VVdiSnlBM3FKeTZETU5UYkNyWkxLazQwX0pWcGdzU3dQanVtYjdqa2dSTGdGd2ZEaGJBYjhDVGItYzNtdWVOYzAwSURpUGVzOWp0Q1JMY1NWUG9zWQ?oc=5","date":"2026-02-13","type":"earnings","source":"BioPharma Dive","summary":"Ultragenyx cuts jobs as it seeks path to profit in 2027 - BioPharma Dive","headline":"Ultragenyx cuts jobs as it seeks path to profit in 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNQU10ZG41S2Y4djZHQ2YzQm1XNlBRRlliV2NsMFFrX1NZRnpYdk5rTWptU01VbWd3LWhlY1JoWC1WM25ITVQwajV6ZTJLYkF0SVJEcXUyNUpmWWZZbHZlM3V3emNoUTZHanl5Tnp2WFNrWFAxbDBBM2Z1MnlyRVNTcl96Mi1YZkozZ1gtSDNWQkQyMFRpOWVrUg?oc=5","date":"2026-01-16","type":"pipeline","source":"BioPharma Dive","summary":"On biotech’s biggest stage, renewed excitement gets a stress test - BioPharma Dive","headline":"On biotech’s biggest stage, renewed excitement gets a stress test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPbnRwNTIwRWpLMHptVnpoTjBjUlRaWmJBaUx3a0VEdnVRUkx4WUpqZXBMeXVtVURsa0FxYmpIYkx4bHZvaUVpVmx6bzNJclM0c1ZPRVNiUkk5UEpudXpWQ0w2alNxUjBudTdRTDVCZTVNVjNPSU1wRnBSNjVrN1FDUWxQblVUTkV6bDBuT1FHOFhaUFU5N2VIaTJqSms4VkJPWHc?oc=5","date":"2026-01-14","type":"pipeline","source":"BioWorld News","summary":"Rage Bio enters clinic with inhaled oligonucleotide in COPD - BioWorld News","headline":"Rage Bio enters clinic with inhaled oligonucleotide in COPD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1weHV4c1dIc2FhMkRKX2hPV09mTndpckw4bFU1S2pvQVJiMFZrREh6STBNejloVV9heTRtdTF0dEtFSGF3bThFeTdTWnBHNEE2eXVFVzY5SWpfOGJqbTJ2NFByVU9ySmVh?oc=5","date":"2025-12-03","type":"deal","source":"Labiotech.eu","summary":"6 obesity deals from 2025 set to change the future of weight loss - Labiotech.eu","headline":"6 obesity deals from 2025 set to change the future of weight loss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQRGpHa21WRGR2M2otRE5hTHdOQVhoUng3RVZLNXZZNHFDQjg1cnBnaWdBQmlGbnVaQVduNk0zaW5vQ1R1TUpDVHlqWHJJWXhOOTVGVnFoQ1lkZ3Q0WVp0eDVTZnhKUV9jY3k1c2FwMklseDJRUEVhTXFGUnlMTkhETUJfV0dxbVNIWHd6RTdiMk5zMkVZSUVCSGFVSmRqbHI1U2hZN1R2bU5lb0E?oc=5","date":"2025-11-13","type":"pipeline","source":"SmartCompany","summary":"RAGE Biotech raises $29 million for new lung disease treatment - SmartCompany","headline":"RAGE Biotech raises $29 million for new lung disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPck82akxuOUI4YjhjUFQzU0FpbjllQ2RJZ2dKbEE3Zi1fdVJoTFBBNVNBNUJjSkp1Y3V6Nk8ybGRrLWlPbml6VUctbExzZFV6VUMxenE4MDRWQmQ1WFpPUmp6T3VVVFJjVWhzMHpmQkZobE1BSExqN1RmdUkxUGQwcnVDbWVuT2NvVGQyY3padmwxY0x3RmcyV1dWUXJfMWZScWtRa09EYndkTzlxNzAwaTJjTDRHd1BVNmZ0MjIzQi1ta1FQQnc?oc=5","date":"2025-11-11","type":"pipeline","source":"European Medical Journal","summary":"IL-33 Is Not Just IL-33: There Is More Than One Side to the COPD Story - European Medical Journal","headline":"IL-33 Is Not Just IL-33: There Is More Than One Side to the COPD Story","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQdW1qVHVxczRnSVBDdW1fWTBQRGRvWFpzTXQ3VUN3dEdEX3hoUEhJV2lqLXpIbmFUaDZndS1FMDZvZkRYOUx6akFrMi1nd09RSHFubVU2WU1fUlZBaHhNVFBkb01ac2hxb1RYUThySWluSWZRTnptZXlUUUFpRnpfY2Y1dGZCcGNqUzNKcXZmSXpoOFNrNHlIdHZ5VQ?oc=5","date":"2025-07-14","type":"regulatory","source":"BioPharma Dive","summary":"FDA rejects Ultragenyx gene therapy over manufacturing concerns - BioPharma Dive","headline":"FDA rejects Ultragenyx gene therapy over manufacturing concerns","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNMmZfY01zR3lLTFhJalE0UmVYcXc1cGZSS3l5NHNyeFg1Y0RSVlRybHlOdHAya1BpZWVyb2VyWFdobnJMemliS2pkS0RWZWYtWG8wY0p2NUN4S0tjbkRUeWpfWlh5clcyZUNUSUM3ODU0dTEydXc4NEVQMW1CUXRFVHktOXZZUlo1enlLcXFYZDJkbFhyTGFwdW00X21TYWZYSWZVYzlxLXdCNURrUzV4OWhQNnA?oc=5","date":"2025-02-26","type":"pipeline","source":"BioSpace","summary":"How To Mine Biopharma’s IP Storeroom for Rare Disease Drugs, Just Like SpringWorks - BioSpace","headline":"How To Mine Biopharma’s IP Storeroom for Rare Disease Drugs, Just Like SpringWorks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNRV9Nc3I2TGFSUVRVSThSVHk0WWJFb04zbVZlbWNxS2plblNhX1RoOG9CZklEel93WnNMNzlEYWJ6Zk1aR2NxSzlxX2hwRlNoTmpsaU9YTllnWWFRNWFhTk8zbTJWdktEZUwyLXROTHNraTY4MDR3a0ZaTWlFTGpQV2xCZFVZNGdRSWlRMGp3cTNHYk02Mk9EdmM0SUFwYU5TLVhZdmJVVWZ3ek1rR05MZFhfU1RMNVd1ZHNMYw?oc=5","date":"2024-02-26","type":"pipeline","source":"cwcolumbus.com","summary":"Amgen opens 300,000-square-foot facility in Central Ohio - cwcolumbus.com","headline":"Amgen opens 300,000-square-foot facility in Central Ohio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxPMV8tOGNBLUJ2ZmxmV3NNXzd2OGR6TG9KdV81Tkd5RDRKdHRfMmxXLUwtalBWcTV3OGdwSFpWamoxcnZBRGtQMFgtNWQ1VXVKTVp1TVExMllSNU1kOWtWZU9RM0pvN0dqZG00bWpNdjhvSjNoMHhaWTJDbGFIQ0ZscEhWdXF1QmhrdG51dmpRaUU5V0ZRU3NxWDNqb0d3TDNlNnNmUTN4bkZnNVZ0SHU5MUZIS1FuT3dsMGxHQnBoaEtid2J0U3VkdXgwUE4yanVFaEVGRnlKX2czNmNwbWNDa2YwS1IwTkM0RHJaNDRQcGYtX2NRV2JxQ3o3dXpwalRZbU1GRg?oc=5","date":"2023-11-16","type":"pipeline","source":"Pharmaceutical Executive","summary":"Should Biopharma C-Suites Still Engage With China? A Harvard Business School Healthcare Alumni Association Q&A with Professor F. Warren McFarlan - Pharmaceutical Executive","headline":"Should Biopharma C-Suites Still Engage With China? A Harvard Business School Healthcare Alumni Association Q&A with Prof","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPS2J1ekx2dVRjQnVjREpVLUVORFlzN3lrSE16MDcxMENLUVU1VF9BSEJDa3Y2dDdiY1lscU1HOUZESWRGd3JZTXNpTXVjS1lIU29OM3pqT1hYNVZ5VjdGX1FNdHdGYnJlajdnZlVRcnhQWFF4WFM0OW9qdmtEbXNfZjNhQ0g1VHFkelVsNUsyeHVyd3VW?oc=5","date":"2023-07-01","type":"pipeline","source":"BioPharm International","summary":"Weighing the Benefits of Single-Use Consumables - BioPharm International","headline":"Weighing the Benefits of Single-Use Consumables","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOa01RSlB0Z2htYWc4ZXN0ZU01QzVFaUZSYkVrWmVMZ21lMVA3QzBxc3FfU0U4Z2o5eHJQR3l5aXN4OEU4ZFp4dkYwSE0wODVHZHNxU25ZUUx5NERMUDhBemF5VmZoSXVCYnhlRm8wVmV1aU9QTmhyWmpfOWY0dkNxOEdrdmx4cjZFSEYzOGxFcDZRaVJVR2U3V1cxMms5aGozRU1JbEVFdUdRY1FxTkYzd2FiaEVxYk5DOU11bnRBdDRjeUF6?oc=5","date":"2022-10-26","type":"pipeline","source":"Fierce Pharma","summary":"Bone Therapeutics joins biotech name change rage, rebranding as BioSenic - Fierce Pharma","headline":"Bone Therapeutics joins biotech name change rage, rebranding as BioSenic","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}